| Primary |
| Drug Use For Unknown Indication |
23.2% |
| Lyme Disease |
17.6% |
| Product Used For Unknown Indication |
16.8% |
| Babesiosis |
16.0% |
| Parasite Blood Test Positive |
4.0% |
| Antifungal Prophylaxis |
2.4% |
| Depression |
2.4% |
| Prophylaxis |
2.4% |
| Granulomatosis With Polyangiitis |
1.6% |
| Hiv Infection |
1.6% |
| Hormone Replacement Therapy |
1.6% |
| Multiple Myeloma |
1.6% |
| Pneumocystis Jirovecii Pneumonia |
1.6% |
| Sepsis |
1.6% |
| Vasculitis |
1.6% |
| Abdominal Pain Upper |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Glaucoma |
0.8% |
| Herpes Zoster |
0.8% |
| Hypertension |
0.8% |
|
| Product Quality Issue |
11.6% |
| Death |
8.7% |
| Nausea |
8.7% |
| Pharmaceutical Product Complaint |
8.7% |
| Vomiting |
8.7% |
| Drug Ineffective |
5.8% |
| Cerebrovascular Accident |
4.3% |
| Diarrhoea |
4.3% |
| Pyrexia |
4.3% |
| Vision Blurred |
4.3% |
| Xanthopsia |
4.3% |
| Abdominal Pain |
2.9% |
| Brain Neoplasm Malignant |
2.9% |
| Headache |
2.9% |
| Hospice Care |
2.9% |
| Kaposi's Sarcoma |
2.9% |
| Myalgia |
2.9% |
| Neutropenia |
2.9% |
| Off Label Use |
2.9% |
| Overdose |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.1% |
| Infection Parasitic |
12.8% |
| Granulomatosis With Polyangiitis |
7.7% |
| Hiv Infection |
7.7% |
| Chronic Lymphocytic Leukaemia |
5.1% |
| Depression |
5.1% |
| Premedication |
5.1% |
| Prophylaxis |
5.1% |
| Blood Cholesterol Increased |
3.8% |
| Eye Infection Toxoplasmal |
3.8% |
| Babesiosis |
2.6% |
| Bone Marrow Transplant |
2.6% |
| Haematopoietic Stem Cell Mobilisation |
2.6% |
| Pneumonia Primary Atypical |
2.6% |
| Sleep Apnoea Syndrome |
2.6% |
| Tumour Lysis Syndrome |
2.6% |
| Insomnia |
1.3% |
| Lyme Disease |
1.3% |
| Malaria |
1.3% |
| Neuropathy Peripheral |
1.3% |
|
| Vomiting |
17.4% |
| Cardiac Failure |
8.7% |
| Neck Pain |
8.7% |
| Pain In Extremity |
8.7% |
| Gastroenteritis |
4.3% |
| Interstitial Lung Disease |
4.3% |
| Neoplasm Malignant |
4.3% |
| Neuropathy Peripheral |
4.3% |
| Pericardial Effusion |
4.3% |
| Platelet Count Decreased |
4.3% |
| Pneumonia Primary Atypical |
4.3% |
| Sensory Disturbance |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Urticaria |
4.3% |
| Vertigo |
4.3% |
| Visual Impairment |
4.3% |
| Weight Increased |
4.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.0% |
| Product Used For Unknown Indication |
20.3% |
| Hiv Infection |
16.4% |
| Multiple Myeloma |
4.7% |
| Prophylaxis |
4.5% |
| Pain |
3.7% |
| Osteoporosis |
3.6% |
| Systemic Lupus Erythematosus |
3.1% |
| Nausea |
3.0% |
| Chronic Lymphocytic Leukaemia |
2.8% |
| Depression |
2.4% |
| Lyme Disease |
1.9% |
| Constipation |
1.8% |
| Vomiting |
1.5% |
| Hypertension |
1.4% |
| Antifungal Prophylaxis |
1.4% |
| Neuropathy Peripheral |
1.2% |
| Insomnia |
1.2% |
| Acute Myeloid Leukaemia |
1.1% |
| Bacterial Infection |
1.1% |
|
| Wound Infection Staphylococcal |
13.3% |
| Vomiting |
12.7% |
| Pneumonia |
6.1% |
| Pyrexia |
6.1% |
| Thrombocytopenia |
6.1% |
| Renal Failure Acute |
5.5% |
| Death |
4.8% |
| Sepsis |
4.8% |
| Rash |
4.2% |
| Rhabdomyolysis |
4.2% |
| Weight Decreased |
4.2% |
| Abdominal Pain |
3.6% |
| Diarrhoea |
3.6% |
| Pancreatitis Acute |
3.0% |
| Pancytopenia |
3.0% |
| Rectal Haemorrhage |
3.0% |
| Renal Failure |
3.0% |
| Septic Shock |
3.0% |
| Staphylococcal Sepsis |
3.0% |
| Diabetes Mellitus |
2.4% |
|
